IBRN.US iShares Trust - iShares Neuroscience and Healthcare ETF
- Total assets
- 8.85M
- Expense ratio
- 0.45%
- Dividend yield
- 0.99%
- 1-year return
- +23.00%
- Holdings
- 67
- Since
- 2022
Fund data as reported by the issuer, updated Nov 15, 2026. Total assets are in the fund's base currency.
What does IBRN.US invest in?
- Mostly US stocks (80.0%)
- Largest sector: Healthcare (100.0%)
- Largest region: North America (77.2%)
- Top 3 holdings: 15.9% of the fund
Asset allocation
- US stocks 80.0%
- Non-US stocks 22.4%
- Cash 0.1%
Top holdings
- Biogen Inc 5.55%
- Neurocrine Biosciences Inc 5.20%
- Edgewise Therapeutics Inc 5.15%
- Alkermes Plc 4.62%
- argenx NV ADR 4.60%
iShares Trust - iShares Neuroscience and Healthcare ETF performance
Sharpe ratio 0.66- This year
- +9.54%
- 1 year
- +23.00%
- 3 years
- +22.40%
- 5 years
- -
Volatility 22.7% over 1 year and 24.5% over 3 years. High: expect large swings.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
IBRN.US price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
About iShares Trust - iShares Neuroscience and Healthcare ETF
The fund will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents as well as in securities not included in the index, but which BFA believes will help the fund track the index.
Full fund profileiShares Trust - iShares Neuroscience and Healthcare ETF top holdings
46.0% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| Biogen Inc BIIB.US | Healthcare | United States | 5.55% |
| Neurocrine Biosciences Inc NBIX.US | Healthcare | United States | 5.20% |
| Edgewise Therapeutics Inc EWTX.US | Healthcare | United States | 5.15% |
| Alkermes Plc ALKS.US | Healthcare | United States | 4.62% |
| argenx NV ADR ARGX.US | Healthcare | United States | 4.60% |
| PTC Therapeutics Inc PTCT.US | Healthcare | United States | 4.47% |
| Axogen Inc AXGN.US | Healthcare | United States | 4.41% |
| Praxis Precision Medicines Inc PRAX.US | Healthcare | United States | 4.18% |
| Dianthus Therapeutics Inc. DNTH.US | Healthcare | United States | 4.03% |
| Sk Biopharmaceuticals Co Ltd 326030.KO | Healthcare | Korea | 3.78% |
The 10 largest of 67 holdings.
IBRN.US sector exposure
- Healthcare100.0%
Share of the stocks in the fund.
IBRN.US regional exposure
- North America77.2%
- Europe Developed9.9%
- Asia Developed3.6%
- Asia Emerging2.8%
- Japan2.1%
- Africa/Middle East0.6%
Share of the stocks in the fund.
Company size
Average market cap 3.56B- Medium cap17.8%
- Small cap43.3%
- Micro cap32.6%
iShares Trust - iShares Neuroscience and Healthcare ETF fund profile
- Fund name
- iShares Trust - iShares Neuroscience and Healthcare ETF
- Ticker
- IBRN.US
- Exchange
- USA Stocks
- Issuer
- iShares
- Index tracked
- -
- Category
- Healthcare Equity
- Inception date
- Aug 24, 2022
- Trading currency
- USD
- Expense ratio
- 0.45%
- Annual turnover
- 0.6%
About iShares Trust - iShares Neuroscience and Healthcare ETF
The fund will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents as well as in securities not included in the index, but which BFA believes will help the fund track the index.